A detailed history of Raymond James Financial Services Advisors, Inc. transactions in Stereotaxis, Inc. stock. As of the latest transaction made, Raymond James Financial Services Advisors, Inc. holds 34,000 shares of STXS stock, worth $65,960. This represents 0.0% of its overall portfolio holdings.

Number of Shares
34,000
Previous 35,887 5.26%
Holding current value
$65,960
Previous $65,000 6.15%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

SELL
$1.76 - $2.35 $3,321 - $4,434
-1,887 Reduced 5.26%
34,000 $69,000
Q1 2024

Apr 22, 2024

BUY
$1.74 - $3.16 $33,060 - $60,040
19,000 Added 112.51%
35,887 $93,000
Q3 2023

Oct 24, 2023

SELL
$1.42 - $1.84 $1,420 - $1,840
-1,000 Reduced 5.59%
16,887 $26,000
Q2 2023

Jul 25, 2023

BUY
$1.51 - $2.27 $27,009 - $40,603
17,887 New
17,887 $27,000

Others Institutions Holding STXS

About Stereotaxis, Inc.


  • Ticker STXS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 74,790,096
  • Market Cap $145M
  • Description
  • Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. Its robotic magnetic navigation (RMN) systems include the Genesis RMN and Niobe systems, which enable physicians to complete complex interventional procedures by pr...
More about STXS
Track This Portfolio

Track Raymond James Financial Services Advisors, Inc. Portfolio

Follow Raymond James Financial Services Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James Financial Services Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Raymond James Financial Services Advisors, Inc. with notifications on news.